Analysts’ Weekly Ratings Updates for InnovAge (INNV)

Several brokerages have updated their recommendations and price targets on shares of InnovAge (NASDAQ: INNV) in the last few weeks:

• 5/18/2026 – InnovAge was downgraded by Weiss Ratings from “hold (c-)” to “sell (d-)”.
• 5/17/2026 – InnovAge was downgraded by Wall Street Zen from “buy” to “hold”.
• 5/9/2026 – InnovAge was downgraded by Wall Street Zen from “strong-buy” to “buy”.
• 5/4/2026 – InnovAge had its “hold (c-)” rating reaffirmed by Weiss Ratings.
• 4/24/2026 – InnovAge was downgraded by Zacks Research from “strong-buy” to “hold”.

InnovAge Holdings, Inc (NASDAQ:INNV) is a healthcare services company that specializes in caring for seniors through the Program of All-Inclusive Care for the Elderly (PACE). Designed for individuals who are eligible for both Medicare and Medicaid, the PACE model integrates medical care, social services and long-term care—delivered primarily in participants’ homes and community-based centers. InnovAge’s approach centers on interdisciplinary care teams that coordinate everything from primary and specialty medical services to nutritional counseling and recreational activities.

The company’s core offerings include comprehensive in-home assessments, physician and nursing services, physical and occupational therapy, prescription medication management, and transportation to medical appointments.